Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Sale | 2024-02-22 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 567,650 4.700% | -164,331 (-22.45%) | Filing History |
| 2024-09-23 1:28 pm Sale | 2024-08-31 | 13D | Lexaria Bioscience Corp. LEXXW | Boos Wayne W | 600,000 3.795% | -315,425 (-34.46%) | Filing History |
| 2024-08-06 4:11 pm Sale | 2024-07-31 | 13D | Lexaria Bioscience Corp. LEXXW | Boos Wayne W | 915,425 5.790% | -104,575 (-10.25%) | Filing History |
| 2024-04-25 4:57 pm Purchase | 2024-03-31 | 13D | Lexaria Bioscience Corp. LEXXW | Boos Wayne W | 1,020,000 8.050% | 540,000 (+112.50%) | Filing History |
| 2024-02-14 2:20 pm Purchase | 2023-12-31 | 13D | Lexaria Bioscience Corp. LEXXW | Boos Wayne W | 480,000 4.671% | 30,000 (+6.67%) | Filing History |
| 2024-02-14 12:00 pm Purchase | 2023-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 731,981 7.120% | 258,878 (+54.72%) | Filing History |
| 2023-09-18 10:42 am Purchase | 2023-09-01 | 13D | Lexaria Bioscience Corp. LEXXW | Boos Wayne W | 450,000 5.561% | 450,000 (New Position) | Filing History |
| 2023-02-10 4:06 pm Purchase | 2022-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 473,103 7.950% | 113,990 (+31.74%) | Filing History |
| 2022-02-11 5:49 pm Sale | 2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX | L1 Capital Global Opportunities Master Fund, Ltd. | 159,000 2.600% | -126,714 (-44.35%) | Filing History |
| 2022-02-11 5:33 pm Purchase | 2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX | Invenomic Capital Management LP | 359,113 6.030% | 359,113 (New Position) | Filing History |
| 2021-02-23 9:04 pm Purchase | 2021-01-14 | 13D | Lexaria Bioscience Corp. LEXX | BUNKA CHRISTOPHER | 489,455 9.500% | 489,455 (New Position) | Filing History |
| 2021-01-20 4:05 pm Purchase | 2021-01-12 | 13G | Lexaria Bioscience Corp. LEXX | L1 Capital Global Opportunities Master Fund, Ltd. | 285,714 5.600% | 285,714 (New Position) | Filing History |